Toggle navigation
About
Abstract
Editorial Board
Subscription & Newsletter
Contact
Issues
This issue
23-3
All issues
Download PDF
Download EPUB
Editor's Selection
This issue
23-3
Browse by topic
Browse by contributor
Dialogue & Opinion
Abstracts
Abstracts
Search
Classification List
Abstracted Journals
Index of Authors
News & Reports
Home
Abstracts
Journals
Journal #2602
advertisement
Frontiers in pharmacology
13
Showing records 1 to 13 |
Display all abstracts in
Frontiers in pharmacology
106370
Pharmacological evaluation of enantiomerically separated positive allosteric modulators of cannabinoid 1 receptor, GAT591 and GAT593
Brandt AL
Frontiers in pharmacology
2022; 13: 919605
106221
Clinical pharmacology and pharmacogenetics of prostaglandin analogues in glaucoma
Zhou L
Frontiers in pharmacology
2022; 13: 1015338
105975
AZD6738 Inhibits fibrotic response of conjunctival fibroblasts by regulating checkpoint kinase 1/ and / pathways
Huang L
Frontiers in pharmacology
2022; 13: 990401
106370
Pharmacological evaluation of enantiomerically separated positive allosteric modulators of cannabinoid 1 receptor, GAT591 and GAT593
Garai S
Frontiers in pharmacology
2022; 13: 919605
105975
AZD6738 Inhibits fibrotic response of conjunctival fibroblasts by regulating checkpoint kinase 1/ and / pathways
Ye Q
Frontiers in pharmacology
2022; 13: 990401
106221
Clinical pharmacology and pharmacogenetics of prostaglandin analogues in glaucoma
Zhan W
Frontiers in pharmacology
2022; 13: 1015338
105975
AZD6738 Inhibits fibrotic response of conjunctival fibroblasts by regulating checkpoint kinase 1/ and / pathways
Lan C
Frontiers in pharmacology
2022; 13: 990401
106221
Clinical pharmacology and pharmacogenetics of prostaglandin analogues in glaucoma
Wei X
Frontiers in pharmacology
2022; 13: 1015338
106370
Pharmacological evaluation of enantiomerically separated positive allosteric modulators of cannabinoid 1 receptor, GAT591 and GAT593
Zagzoog A; Hurst DP
Frontiers in pharmacology
2022; 13: 919605
105975
AZD6738 Inhibits fibrotic response of conjunctival fibroblasts by regulating checkpoint kinase 1/ and / pathways
Wang X
Frontiers in pharmacology
2022; 13: 990401
106370
Pharmacological evaluation of enantiomerically separated positive allosteric modulators of cannabinoid 1 receptor, GAT591 and GAT593
Stevenson LA
Frontiers in pharmacology
2022; 13: 919605
105975
AZD6738 Inhibits fibrotic response of conjunctival fibroblasts by regulating checkpoint kinase 1/ and / pathways
Zhu Y
Frontiers in pharmacology
2022; 13: 990401
106370
Pharmacological evaluation of enantiomerically separated positive allosteric modulators of cannabinoid 1 receptor, GAT591 and GAT593
Pertwee RG; Imler GH; Reggio PH; Thakur GA; Laprairie RB
Frontiers in pharmacology
2022; 13: 919605
Issue
23-3
Table of Contents
Editor's Selection
PDF
EPUB
Change Issue
26-1
25-4
25-3
25-2
25-1
24-4
24-3
24-1/2
23-4
23-3
23-2
23-1
22-4
22-3
22-2
22-1
21-4
21-3
21-2
21-1
20-4
20-3
20-2
20-1
19-4
19-3
19-2
19-1
18-4
18-3
18-2
18-1
17-4
17-3
17-2
17-1
16-4
16-3
16-2
16-1
15-4
15-3
15-2
15-1
14-4
14-3
14-2
14-1
13-4
13-3
13-2
13-1
12-4
12-3
12-2
12-1
11-4
11-3
11-2
11-1
10-4
10-3
10-2
10-1
9-4
9-3
9-2
9-1
8-4
8-3
8-2
8-1
7-3
7-2
7-1
6-3
6-2
6-1
5-3
5-2
5-1
4-3
4-2
4-1
3-3
3-2
3-1
2-3
2-2
2-1
1-3
1-2
1-1
advertisement
We would like to use Google Analytics to see which parts of the review are read. It is only used to count visits, never for advertising.
Privacy statement
Decline
Accept